Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Stacy Cline Amin, former Chief Counsel of the Food and Drug Administration, spoke with Bloomberg Law about how FDA might transition more than 400 products from emergency use status to approved status, if the public health emergency with COVID-19 ends.

End of Health Crisis Will Put Heaps of Covid Products in Limbo

About Morrison Forester

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Stacy Cline Amin, former Chief Counsel of the Food and Drug Administration, spoke with Bloomberg Law about how FDA might transition more than 400 products from emergency use status to approved status, if the public health emergency with COVID-19 ends.“The sheer volume of authorized products could be potentially very disruptive, if not transitioned well by FDA,” said Stacy. “FDA is aware of that and thinking about it.”The emergency also may not go away anytime soon, with the emergence of new variants and as the pandemic continues to rage globally, Amin noted.“It may not be the case that the public health emergency for us is really, you know, coming to a quick close,” she said.Read the <a target="_blank" href="https://www.bloomberglaw.com/product/blaw/document/QWL9DHDWLU6F?criteria_id=af6bfeba3cd45dab59c5af083939f8a4&searchGuid=16113c19-03f9-434e-bfa3-9d19430d0bad">full article </a>(subscription required).